MND genetics research in WA recognised by international expert

The work of Perron Institute and Murdoch University researchers has recently received international attention. They are uncovering genetic mechanisms that are leading towards future genetic therapies for motor neurone disease (MND). Two peer reviewed scientific papers on this theme have been referenced in a year-in-review article recently published by Neurology Genetics, the official journal of… Continue reading MND genetics research in WA recognised by international expert

Published
Categorized as News

1 million grant from FightMND supports testing for motor neurone disease potential treatment

Finding treatments for motor neurone disease is the goal of WA neuroscientists who have received a one million dollar grant from Australian MND foundation FightMND. It’s part of a total of $10.68m for 16 projects nationwide announced today. This is the first drug development grant for Western Australia provided by FightMND. Researchers at the Perron… Continue reading 1 million grant from FightMND supports testing for motor neurone disease potential treatment

Published
Categorized as News

BSP launches its portfolio of antisense therapeutics through its partnership with The Perron Institute in Western Australia

Accelerating the conversion of laboratory research findings into clinical trials is the focus of a new partnership between the Perron Institute in Western Australia and United States based biotech company Black Swan Pharmaceuticals. Black Swan Pharmaceuticals’ goal is to be a translational research engine, fast-tracking the development and clinical availability of novel therapeutic molecules so… Continue reading BSP launches its portfolio of antisense therapeutics through its partnership with The Perron Institute in Western Australia

Published
Categorized as News